X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (2) 2
aged (1) 1
allergy and immunology (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bevacizumab (1) 1
brain (1) 1
brain neoplasms - drug therapy (1) 1
brain neoplasms - genetics (1) 1
brain neoplasms - mortality (1) 1
brain neoplasms - pathology (1) 1
cancer research (1) 1
care and treatment (1) 1
clinical-trial (1) 1
confidence intervals (1) 1
dacarbazine - analogs & derivatives (1) 1
dacarbazine - therapeutic use (1) 1
dendritic cell (1) 1
disease-free survival (1) 1
dna modification methylases - genetics (1) 1
dna repair enzymes - genetics (1) 1
dose-response relationship, drug (1) 1
drug administration schedule (1) 1
early detection of cancer - methods (1) 1
expression (1) 1
female (1) 1
follow-up studies (1) 1
glioblastoma - drug therapy (1) 1
glioblastoma - genetics (1) 1
glioblastoma - mortality (1) 1
glioblastoma - pathology (1) 1
glioblastoma multiforme (1) 1
hematology, oncology and palliative medicine (1) 1
humans (1) 1
immunology (1) 1
index medicus (1) 1
integrin alphabeta (1) 1
integrins (1) 1
kaplan-meier estimate (1) 1
male (1) 1
malignant glioma (1) 1
maximum tolerated dose (1) 1
medical research (1) 1
medicine & public health (1) 1
medicine, experimental (1) 1
middle aged (1) 1
neoplasm invasiveness - pathology (1) 1
neoplasm staging (1) 1
patient selection (1) 1
promoter regions, genetic (1) 1
proportional hazards models (1) 1
radiotherapy (1) 1
recurrent glioblastoma (1) 1
reference values (1) 1
rna electroporation (1) 1
snake venoms - therapeutic use (1) 1
survival analysis (1) 1
temozolomide (1) 1
topoisomerase ii alpha (1) 1
treatment outcome (1) 1
tumor antigen (1) 1
tumor suppressor proteins - genetics (1) 1
united-states (1) 1
vaccine (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1100 - 1108
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 5/2010, Volume 59, Issue 5, pp. 747 - 757
Topoisomerase II alpha (Top2α) is an attractive candidate to be used as a tumor antigen for cancer immunotherapy, because it is abundantly expressed in various... 
Dendritic cell | Immunology | Medicine & Public Health | Tumor antigen | Oncology | Cancer Research | Topoisomerase II alpha | Vaccine | RNA electroporation | Rna electroporation | Topoisomerase ii alpha
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.